BIOGEN INC. Operating Income Loss

• BIOGEN INC. showed a decrease of -37.6% in Operating Income Loss from 2020 to 2021.
• This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 3, 2022.
• XBRL data for this metric is available from 2007 to 2021 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2007 to 2021), BIOGEN INC.'s Operating Income Loss has grown by 264.3%.
• Historical annual values: Fiscal year 2021: $2.84 billion | Fiscal year 2020: $4.55 billion | Fiscal year 2019: $7.04 billion | Fiscal year 2018: $5.89 billion | Fiscal year 2017: $5.35 billion | Fiscal year 2016: $5.15 billion | Fiscal year 2015: $4.89 billion | Fiscal year 2014: $3.97 billion | Fiscal year 2013: $2.52 billion | Fiscal year 2012: $1.86 billion | Fiscal year 2011: $1.72 billion | Fiscal year 2010: $1.25 billion | Fiscal year 2009: $1.30 billion | Fiscal year 2008: $1.21 billion | Fiscal year 2007: $779.77 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026